What is Crizotinib?

Category: Prescription Drugs

Most popular types: Xalkori

false

Crizotinib is an orally administered product that may be used for the treatment of metastatic non-small cell lung cancer that is positive for anaplastic lymphoma kinase (ALK).

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Adenocarcinoma (non-small cell lung cancer) 14 12
Adenosquamous carcinoma (non-small cell lung cancer) 2 2
Lung cancer 2 0
Non-small cell lung cancer 1 2

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
1
Moderate
4
Mild
8
None
1

Commonly reported side effects and conditions associated with Crizotinib

Side effect Patients
Diarrhea 3
Swelling in legs, feet and ankles 3
Edema (fluid retention) 2
Fatigue 2
Nausea 2
Blurry vision 1

Show all 20 reported side effects

Dosages

Based on patients currently taking Crizotinib

Dosage Patients
250 mg twice daily 6
1 capsule(s) twice daily 1

Why patients stopped taking Crizotinib

Multiple reasons could be selected

Reason Patients
Did not seem to work 5
Doctor's advice 4
Side effects too severe 2
See all 7 patients who've stopped taking Crizotinib

Duration

Currently taking Crizotinib

Duration Patients
6 months - 1 year 3
1 - 2 years 2
2 - 5 years 2

Stopped taking Crizotinib

Duration Patients
1 - 6 months 1
6 months - 1 year 1
1 - 2 years 1
2 - 5 years 3
Adherence
Adherence Evaluations
Always 13
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 14
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 1
< $25 5
Not specified 8

What people switch to and from

Patients started taking Crizotinib after stopping:

Treatment Patients
Chemotherapy 2
Alectinib (Alecensa) 1

Patients stopped taking Crizotinib and switched to:

Treatment Patients
Alectinib (Alecensa) 5
Ceritinib (Zykadia) 1
Last updated:
There are no evaluations for Crizotinib.